ALERTS: MERGERS - EUROPEAN UNION - HEALTHCARE - PHARMACEUTICAL INDUSTRY - INTERIM MEASURES - GUN JUMPING

Interim measures: The European Commission sends a statement of objections to two pharmaceutical companies informing them of the interim measures it intends to adopt (Grail / Illumina)

KEYWORDS
Reference

Eur. Comm., Sep. 20th, 2021, Press Comm. IP/21/4804, Mergers: The Commission adopts a Statement of Objections in view of adopting interim measures following Illumina’s early acquisition of GRAIL

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The European Commission and Illumina are at loggerheads over the proposed acquisition of Grail. The Commission is now threatening to put its money where its mouth is. Today, September 20, 2021, the Commission sent a Statement of Objections to Illumina and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.

PDF Version

Author

  • L’actu-concurrence (Paris)
    France 4280 contributions 984266 visits

Quotation

Alain Ronzano, Interim measures: The European Commission sends a statement of objections to two pharmaceutical companies informing them of the interim measures it intends to adopt (Grail / Illumina), 20 September 2021, Concurrences N° 1-2022, Art. N° 102514, www.concurrences.com

Visites 176

All reviews